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ABSTRACT
Background/Aims: The aim of the present study was to analyze the diagnostic accuracy of serum eosinophilic cationic protein (ECP) 
for eosinophilic esophagitis (EoE) and the correlation of ECP with clinical, histopathological, laboratory, and endoscopic features of EoE.
Materials and Methods: Fifteen patients with EoE and 14 healthy controls were included in the study. Demographic parameters were 
recorded. EoE Endoscopic Reference Score (EREFS) was calculated according to endoscopic features, and esophageal biopsies were 
obtained by a single experienced endoscopist in a patient group. Serum ECP levels (μg/mL), absolute eosinophil count (U/mm3), and 
maximum peak of eosinophils/high-power field in esophageal biopsies were analyzed.
Results: The median age of all participants was 33.0 (min-max: 18-46) years. There were 27 (93.1%) male patients. Serum ECP level 
was significantly higher in patients with EoE than in healthy volunteers (20.4 vs. 8.8, p<0.0001). According to the receiver operating 
characteristic (ROC) curve analysis, ECP had 80% sensitivity and 92.8% specificity to diagnose EoE with a cut-off value of 13.9 μg/mL 
(area under the ROC curve 0.895; p<0.0001; 95% CI: 0.725-0.978). EREFS (p<0.0001) and the presence of food impaction (p=0.04) were 
significantly correlated with ECP.
Conclusion: Serum ECP is an accurate non-invasive biomarker for EoE with high specificity and sensitivity. In addition, ECP is strongly 
correlated with EREFS and the symptom of food impaction.
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INTRODUCTION
Eosinophilic esophagitis (EoE) is a chronic esophageal 
inflammatory disease that is mediated by immunogen-
ic/antigenic (primarily food allergen) mechanisms. It 
is characterized by esophageal symptoms (dysphagia, 
heartburn, and chest pain) caused by esophageal dys-
function and eosinophilic esophageal inflammation (>15 
eosinophilic granulocytes/high-power field (hpf)) (1,2). 
The prevalence of EoE in children and adults has been 
increasing steadily over the past decade (3-5). However, 
it is not clear if this is a true increase in prevalence or an 
artificial result due to improved understanding of the dis-
ease by physicians, enabling a higher rate of diagnosis (6).
Eosinophilic esophagitis Endoscopic Reference Score 
(EREFS) has been recently described to guide physicians 
for recognizing and reporting the main endoscopic find-
ings of EoE (Table 1) (8). It has been documented that 
EREFS has a good inter- or intra-observer agreement. It is 
a simple scoring system with an accurate diagnostic util-
ity that shows the severity of the disease and probability 
of response to treatment (8,9).
In addition to endoscopic/histopathological findings, 
some non-invasive serological markers have been studied 
for the diagnosis of EoE. Increased serum total IgE levels 
have been shown in active EoE disease (10). The diagnos-
tic role of peripheral blood eosinophil count and eosino-
phil-derived proteins (eosinophil-derived neurotoxin and 
major basic protein) has been documented in previous 
studies. Another eosinophil-derived protein, eosinophilic 
cationic protein (ECP), has been studied and shown to be 
accurate in the clinical monitoring of asthma and allergic 
rhinoconjunctivitis (11). However, data regarding the di-
agnostic accuracy of ECP for EoE are extremely rare.
In the present study, we aimed to analyze serum ECP levels in 
patients with EoE and controls to predict the diagnostic accura-
cy of ECP for EoE and to determine the correlation of ECP with 
clinical symptoms, eosinophilia (histological/peripheral blood), 
and endoscopic reference score of EoE in a patient group.
MATERIAL AND METHODS
Fifteen adult patients with EoE were included consecu-
tively according to the current diagnostic criteria (12) as 
345
Cite this article as: Cengiz C. Serum eosinophilic cationic protein is correlated with food impaction and endoscopic severity in eosinophilic 
esophagitis. Turk J Gastroenterol 2019; 30(4): 345-9.
GASTROINTESTINAL ENDOSCOPY
Corresponding Author: Cem Cengiz; cemcengizmd@yahoo.com  
Received: June 29, 2018 Accepted: September 11, 2018 Available online date: January 21, 2019
© Copyright 2019 by The Turkish Society of Gastroenterology • Available online at www.turkjgastroenterol.org 
DOI: 10.5152/tjg.2019.18529
ORIGINAL ARTICLE
≥15 eosinophils/hpf (eo/hpf) in esophagus biopsies be-
fore and after treatment with proton pump inhibitors for 
8 weeks. The control group included 14 healthy partici-
pants to provide blood sample only for ECP.
Endoscopic procedures were performed by an experi-
enced gastroenterologist (CC) using a flexible 9.9 mm 
gastroscope with a 2.8 mm work channel (GIF-H180J; 
Olympus. Hamburg, Germany). Biopsies from the prox-
imal esophagus were obtained using conventional for-
ceps when there is an endoscopic stigmata of EoE. No 
complications were observed during the endoscopic 
procedure.
Biopsy specimens were sent to the pathology depart-
ment of the TOBB University of Economics and Tech-
nology Hospital. A diagnosis of “histologically compatible 
with EoE” was made with the presence of ≥15 eo/hpf 
clustered in microabscesses.
Venous blood was collected from the participants. Abso-
lute eosinophil count (AEC) was analyzed via an automat-
ed hematology analyzer at the central laboratory of the 
TOBB Economy and Technology University Hospital. ECP 
assay was performed in an affiliated commercial labora-
tory specialized for this type of tests.
ECP assay procedure
1. All reagents, samples, and standards were prepared 
according to the manufacturer’s instructions.
2. One hundred µL of sample was added into each well 
and incubated for 2 h at 37°C.
3. The liquid of each well was removed, and 100 µL of 
biotin antibody was added into each well and incu-
bated for 1 h at 37°C.
4. Each well was aspirated and washed three times.
5. One hundred µL of horseradish peroxidase-avidin 
was added into each well and incubated for 1 h at 
37°C.
6. Each well was aspirated and washed five times.
7. Ninety µL of 3,3′,5,5′-tetramethylbenzidine sub-
strate was added into each well and incubated for 
15-30 min at 37°C.
8. Fifty µL of stop solution was added into each well, 
and the assay was read at 450 nm within 5 min.
Statistical analysis
The Statistical Package for the Social Sciences (SPSS) 
version 16 software (SPSS Inc.; Chicago, IL, USA) was 
used for statistical analysis. Kolmogorov-Smirnov test 
was used to determine the normality of the distribu-
tion of data. Comparisons between the groups were 
performed by the Mann-Whitney U test for non-para-
metric variables. The group characteristics were com-
pared using the Fisher’s exact test and the chi-square 
test. A receiver operating characteristic (ROC) curve 
was used to determine the diagnostic ability of ECP for 
EoE. Pearson’s test was used for correlation analyses. 




Our study included 29 participants (15 consecutive pa-
tients with EoE and 14 age-sex-matched control group). 
The median age of all participants was 33.0 (min-max: 
18-46) years. Twenty-seven (93.1%) participants were 
male. Table 2 shows the demographic characteristics of 
the participants.
Table 1. Eosinophilic Esophagitis Endoscopic Reference Score (EREFS)
Classification and grading
0 1 2 3
Rings None Mild (subtle circumferential ridges) Moderate* Severe**
Exudates None Mild¶ Severe¶¶
Furrows Absent Present
Edemas Absent Loss of clarity, absence of vascular markings
Strictures Absent Present
*Distinct rings that do not impair passage of a standard diagnostic adult endoscope of outer diameter 8-9.5 mm
**Distinct rings that do not permit passage of a diagnostic endoscope
¶Lesions involving <10% of the esophageal surface
¶¶Lesions involving >10% of the esophageal surface
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Clinical characteristics, laboratory findings, and EREFS 
of patients with EoE
Eleven (73.3%) patients with EoE had at least one allergic 
disease. Eight out of the 11 patients had food allergy, three 
had allergic rhinitis, and four (26.7%) had bronchial asthma. 
The most common symptom was dysphagia (9/15, 60.0%) 
among patients with EoE. The median eo/hpf count in 
esophageal biopsy was 40 (min-max: 15-100) while periph-
eral blood eosinophilia was observed in 4 (26.7%) patients 
with EoE. The median EREFS was found to be 3.0 (min-
max: 1.0-6.0) in patients with EoE. Table 2 shows the clinical 
characteristics and laboratory findings of patients with EoE.
Predictive value of ECP for EoE
Eosinophilic cationic protein level was significantly high-
er in patients with EoE than in healthy volunteers (20.4 
vs. 8.8, p<0.0001) (Figure 1). An ROC curve was used to 
determine the predictive value of ECP for EoE. Accord-
ing to this ROC curve analysis, the cut-off value of ECP 
was found to be 13.9 µg/mL (sensitivity: 80% (95% CI: 
51.9-95.7), specificity: 92.8% (95% CI: 66.1-99.8), posi-
tive predictive value: 92.3 (95% CI: 64.0-99.8), and neg-
ative predictive value: 81.2 (95% CI: 54.4-96.0), with an 
area under the ROC curve (AUC) 0.895; p<0.0001; 95% 
CI: 0.725-0.978) (Fig. 2).
Table 2. Demographic, clinical characteristics, and laboratory 
findings of the study groups
EoE (+),  
n=15
EoE (-),  
n=14 p
Age (median, min-max) 33.0 (18-44) 33.0 (18-46) 0.7
Male gender (n, %) 14 (93.3) 13 (92.9) 1.0
Atopic disease
Asthma (n, %) 4 (26.7) -
Allergic rhinitis (n, %) 3 (20.0)
Other AD (n, %) 1 (6.7)
Symptoms
Dysphagia (n, %) 9 (60.0)
Heartburn (n, %) 6 (40.0)
Food impaction 2 (13.3)
Laboratory/histopathological 
finding
Peripheral blood eosinophilia 
(n, %)
4 (26.7)
EC/hpf (esophageal biopsy) 
(median, min-max)
40 (15-100)
AEC (median, min-max) 285  
(205-450)
EREFS (median, min-max) 3.0 (1.0-6.0)
EoE: eosinophilic esophagitis; AD: allergic disease; EC: eosinophil count; 
hpf: high-power field; AEC: absolute eosinophil count; EREFS: Eosinophilic 
Esophagitis Endoscopic Reference Score
Figure 1. Comparison of the median ECP between patients with 
EoE and control group
Figure 2. A receiver operating characteristic curve analysis regarding 
the diagnostic ability of ECP for EoE
347
Turk J Gastroenterol 2019; 30(4): 345-9 Cengiz C. Eosinophilic cationic protein and eosinophilic esophagitis
Correlation of ECP with symptoms, laboratory findings, 
and EREFS
When correlation of ECP with AEC, esophageal tissue eo-
sinophil count, EREFS, and EoE symptoms was analyzed, 
only EREFS (p<0.0001) and the presence of food impac-
tion (p=0.04) were significantly correlated with ECP (Ta-
ble 3).
DISCUSSION
Eosinophilic esophagitis is predominantly seen in male 
patients between 30 and 40 years old. Although it is as-
sumed that the prevalence of EoE is increasing due to 
improvement in the understanding of the disease, it is 
still apparent that EoE is an underdiagnosed entity with 
a delay of diagnosis (6).
Histological examination of the esophageal mucosa is 
required for the exact diagnosis of EoE. Non-invasive di-
agnostic markers have been analyzed in previous studies 
to assist in the diagnosis and monitoring of EoE. With the 
establishment of these non-invasive markers, it is aimed 
to prevent multiple endoscopies that are costly, invasive, 
and associated with risks (13). Several prospective stud-
ies have assessed the potential role of various biomark-
ers, including peripheral eosinophil count, cytokines, and 
chemokines involved in the pathogenesis of EoE (14-17). 
Contradictory results have been documented in studies 
analyzing the diagnostic role of several non-invasive bio-
markers for EoE. In the study by Dellon et al., 14 different 
serum biomarkers showed no significant correlation or 
difference between subjects with EoE and controls (18).
Eosinophils have cytoplasmic granules that degranulate 
on stimulation and release toxic mediators, causing tissue 
damage and inflammation (19). Several studies have re-
ported that in addition to the aforementioned non-inva-
sive markers, the presence of these degranulation prod-
ucts in the esophageal tissue can help to diagnose EoE 
(13,17). In a recent study, Min et al. showed that serum 
ECP is significantly higher in patients with EoE than in 
controls (13). Since elevation of ECP may also be due to 
bronchial inflammation, it is suggested that ECP will be 
beneficial only in patients without asthma (6). However 
in the study by Min et al., higher serum ECP level was an 
independent predictor of EoE when age, sex, and atopic 
disease were evaluated in multivariate analysis. The au-
thors concluded that although ECP can be elevated in 
other atopic diseases, such as asthma or allergic rhinitis, 
it was noteworthy to report since it has remained signifi-
cantly associated with EoE by the multivariate analysis 
(13). In our study, we determined that ECP levels were 
significantly higher in subjects with EoE than in controls. 
In addition, we documented that ECP has very accurate 
sensitivity and specificity values (AUC 0.895; p<0.0001) 
to diagnose EoE.
There are contradictory results in previous studies ana-
lyzing the correlation of ECP with AEC and esophageal 
tissue eosinophil count. In the study by Chehade et al., 
ECP has been found to be significantly higher in pa-
tients with EoE, and a positive correlation was obtained 
between ECP and peripheral eosinophilia, whereas this 
correlation could not be observed between ECP and eo-
sinophil count in esophagus biopsy (20). The findings of 
the study by Rodriguez-Sanchez were similar with the 
aforementioned study (21). However, Min et al. showed a 
significant correlation between ECP and esophageal tis-
sue eosinophil count (13). In our study, differently from 
previous studies, ECP was correlated neither with AEC 
nor with esophageal tissue eosinophil count.
Endoscopic reference score is a recent classification sys-
tem that is used to define the endoscopic features (ede-
mas, rings, exudates, furrows, and strictures) of EoE. This 
grading system has an accurate intra- and inter-observer 
agreement that has been independently validated by sev-
eral investigators from North America and Europe (7,22). 
Shoepfer et al. (23) showed that EREFS is associated 
with symptom severity due to a validated patient-report-
ed outcome instrument for EoE.
Although correlation of non-invasive biomarkers of EoE 
and laboratory/histopathological parameters has been 
studied in several studies, to the best of our knowledge, 
Table 3. Correlation of ECP with symptoms, laboratory findings, and EREFS
Laboratory Symptoms Endoscopy
AEC HPEC Heartburn Dysphagia FI EREFS
r -0.077 0.072 -0.201 0.398 0.525 0.900
p 0.7 0.7 0.4 0.1 0.04 <0.0001
ECP: eosinophilic cationic protein; EREFS: Eosinophilic Esophagitis Endoscopic Reference Score; AEC: absolute eosinophil count; HPEC: histopathological 
eosinophil count; FI: food impaction
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there is no study analyzing the correlation of non-inva-
sive biomarkers with endoscopic features. In the current 
study, we analyzed the correlation of ECP (a non-invasive 
biomarker) with endoscopic grade of EoE (EREFS), AEC, 
esophageal tissue eosinophil count, and EoE symptoms. 
Importantly, we found that EREFS and the presence of 
food impaction symptom were strongly correlated with 
ECP.
In conclusion, we have shown that a non-invasive bio-
marker ECP is an accurate diagnostic tool with high 
specificity and sensitivity. The most striking finding of the 
present study is the significant correlation between ECP 
and EREFS that has not been studied in the literature to 
date. However, a small sample size is a limitation of the 
present study, and further prospective studies with larger 
sample size are needed to confirm the role of biomarkers 
in assessing the diagnosis and symptomatic/endoscopic 
severity of EoE.
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